SAN DIEGO, CA, Certis Oncology Solutions, a precision oncology company, raised $10 million in a Series C funding round.
Certis Oncology Solutions (Certis), a precision oncology and translational science company focused on combining AI-directed drug development with advanced functional testing, announced that it raised $10 million in a Series C funding round, bringing total raised to $42 million.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
